Beijing Konruns Pharmaceutical Co Ltd
SSE:603590

Watchlist Manager
Beijing Konruns Pharmaceutical Co Ltd Logo
Beijing Konruns Pharmaceutical Co Ltd
SSE:603590
Watchlist
Price: 45.04 CNY 1.46% Market Closed
Market Cap: 7.2B CNY

Relative Value

The Relative Value of one Beijing Konruns Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 45.04 CNY, Beijing Konruns Pharmaceutical Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Beijing Konruns Pharmaceutical Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
6
vs Industry
28
Median 3Y
5.8
Median 5Y
5.8
Industry
2.7
Forward
7.7
vs History
6
vs Industry
14
Median 3Y
49.2
Median 5Y
34.5
Industry
21.6
Forward
48.4
vs History
36
vs Industry
19
Median 3Y
43
Median 5Y
42.4
Industry
16.9
vs History
34
vs Industry
15
Median 3Y
35.5
Median 5Y
33.4
Industry
22.9
vs History
6
vs Industry
56
Median 3Y
1.6
Median 5Y
1.7
Industry
2.3
vs History
6
vs Industry
31
Median 3Y
5
Median 5Y
4.8
Industry
3
Forward
8
vs History
6
vs Industry
46
Median 3Y
5.6
Median 5Y
5.5
Industry
5.6
vs History
9
vs Industry
10
Median 3Y
33.3
Median 5Y
31.5
Industry
13.4
Forward
16.3
vs History
9
vs Industry
12
Median 3Y
33.3
Median 5Y
31.5
Industry
16.7
vs History
28
vs Industry
23
Median 3Y
36.8
Median 5Y
36.6
Industry
16.1
vs History
12
vs Industry
7
Median 3Y
47.6
Median 5Y
33.5
Industry
18.9
vs History
23
vs Industry
57
Median 3Y
1.5
Median 5Y
1.6
Industry
2

Multiples Across Competitors

Competitors Multiples
Beijing Konruns Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Beijing Konruns Pharmaceutical Co Ltd
SSE:603590
7.2B CNY 8.2 125.4 190.4 190.4
US
Eli Lilly and Co
NYSE:LLY
1T USD 16.9 54.6 36.7 39.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
491.8B USD 5.3 19.6 16 20.8
CH
Roche Holding AG
SIX:ROG
271.4B CHF 4.4 28.8 12.2 14.3
UK
AstraZeneca PLC
LSE:AZN
220.4B GBP 5.1 31.4 108.8 159.2
US
Merck & Co Inc
NYSE:MRK
274.9B USD 4.3 14.4 10.2 12.1
CH
Novartis AG
SIX:NOVN
218.8B CHF 4.9 19 12 15.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.4 16.3 11.3 13.2
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
144.9B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
CN
Beijing Konruns Pharmaceutical Co Ltd
SSE:603590
Average P/E: 36
125.4
82%
1.5
US
Eli Lilly and Co
NYSE:LLY
54.6
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.6
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.8
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.4
37%
0.8
US
Merck & Co Inc
NYSE:MRK
14.4
15%
1
CH
Novartis AG
SIX:NOVN
19
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
16.3
3%
5.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Beijing Konruns Pharmaceutical Co Ltd
SSE:603590
Average EV/EBITDA: 417.3
190.4
67%
2.8
US
Eli Lilly and Co
NYSE:LLY
36.7
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.2
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.8
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.2
6%
1.7
CH
Novartis AG
SIX:NOVN
12
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
11.3
1%
11.3
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Beijing Konruns Pharmaceutical Co Ltd
SSE:603590
Average EV/EBIT: 1 729.7
190.4
36%
5.3
US
Eli Lilly and Co
NYSE:LLY
39.3
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.8
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.3
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.2
23%
6.9
US
Merck & Co Inc
NYSE:MRK
12.1
8%
1.5
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5